Angiogenic Effect of Saponin Extract from Panax notoginseng on HUVECs In Vitro and Zebrafish In Vivo

被引:85
作者
Hong, Si-Jia [1 ]
Wan, Jian-Bo [1 ]
Zhang, Yi [1 ]
Hu, Guang [1 ]
Lin, Hui-Chao [1 ]
Seto, Sai Wang [2 ]
Kwan, Yiu-Wa [2 ]
Lin, Zhi-Xiu [3 ]
Wang, Yi-Tao [1 ]
Lee, Simon Ming-Yuen [1 ]
机构
[1] Univ Macau, Inst Chinese Med Sci, Taipa, Peoples R China
[2] Chinese Univ Hong Kong, Dept Pharmacol, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China
关键词
angiogenesis; saponin extract from Panax notoginseng (PNS); KDR/Flk-1; PI3K-AKT-eNOS; ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE PRODUCTION; GINSENOSIDE-RE; FACTOR VEGF; PATHWAY; CANCER; HPLC; PHOSPHORYLATION; EXPRESSION; INHIBITOR;
D O I
10.1002/ptr.2705
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Angiogenesis plays an important role in a wide range of physiological processes such as wound healing and fetal development. In fact, many diseases are associated with imbalance in the regulation of angiogenesis in which there is either excessive or insufficient blood vessel formation. Panax notoginseng, a blood circulation invigorating herb, is commonly used in traditional Chinese medicine to treat circulation-related diseases. However, the biological effects of saponin extract from Panax notoginseng (PNS) on angiogenesis and the underlying mechanisms are yet to be fully elucidated. This investigation describes the angiogenic effects of PNS on human umbilical vein endothelial cells (HUVECs) in vitro and zebrafish in vivo. The 2,3-bis(2-methoxy-4-nitro-5-sulfophenvl)5[(phenylamino)carbonyl]2H-tetrazolium hydroxide (XTT) assay and microscopic cell counting demonstrated that the extract was able to stimulate the proliferation of HUVECs. Meanwhile, the numbers of invaded cells and tube branches were significantly increased in PNS treatment groups. PNS was also shown to promote changes in the subintestinal vessels, a feature of angiogenesis, in zebrafish. In addition, by using real-time polymerase chain reaction (PCR), PNS was found to enhance vascular endothelial growth factor (VEGF) and kinase-domain region/fetal liver kinase-1 in mice (KDR/Flk-1.) mRNA expression, and the PNS-induced HUVECs proliferation could be abolished by a KDR/Flk-1 inhibitor. Furthermore, the proliferation of HUVECs induced by PNS was significantly attenuated by inhibitors of PI3K-Akt-eNOS. All the results suggest that PNS can promote angiogenesis, and that the proangiogenic effects involve the VEGF-KDR/Flk-1 and PI3K-Akt-eNOS signaling pathways. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:677 / 686
页数:10
相关论文
共 52 条
[1]   Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis [J].
Ahmad, Shakil ;
Hewett, Peter W. ;
Wang, Ping ;
Al-Ani, Bahjat ;
Cudmore, Melissa ;
Fujisawa, Takeshi ;
Haigh, Jody J. ;
le Noble, Ferdinand ;
Wang, Ling ;
Mukhopadhyay, Debabrata ;
Ahmed, Asif .
CIRCULATION RESEARCH, 2006, 99 (07) :715-722
[2]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[3]   Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay [J].
Amano, Morikazu ;
Suzuki, Minoru ;
Andoh, Satoshi ;
Monzen, Hajime ;
Terai, Kaoru ;
Williams, Brent ;
Song, Chang W. ;
Mayo, Kevin H. ;
Hasegawa, Takeo ;
Dings, Ruud P. M. ;
Griffin, Robert J. .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (01) :42-47
[4]   Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies [J].
Bocci, G ;
Man, S ;
Green, SK ;
Francia, G ;
Ebos, JML ;
du Manoir, JM ;
Weinerman, A ;
Emmenegger, U ;
Ma, L ;
Thorpe, P ;
Davidoff, A ;
Huber, J ;
Hicklin, DJ ;
Kerbel, RS .
CANCER RESEARCH, 2004, 64 (18) :6616-6625
[5]   Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine [J].
Bocci, G ;
Danesi, R ;
Marangoni, G ;
Fioravanti, A ;
Boggi, U ;
Esposito, I ;
Fasciani, A ;
Boschi, E ;
Campani, D ;
Bevilacqua, G ;
Mosca, F ;
Del Tacca, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 498 (1-3) :9-18
[6]   Shear stress stimulates phosphorylation of eNOS at Ser635 by a protein kinase A-dependent mechanism [J].
Boo, YC ;
Hwang, J ;
Sykes, M ;
Michell, BJ ;
Kemp, BE ;
Lum, H ;
Jo, H .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (05) :H1819-H1828
[7]   Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide [J].
Bussolati, B ;
Dunk, C ;
Grohman, M ;
Kontos, CD ;
Mason, J ;
Ahmed, A .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (03) :993-1008
[8]   Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS [J].
Cai, J ;
Jiang, WG ;
Ahmed, A ;
Boulton, M .
MICROVASCULAR RESEARCH, 2006, 71 (01) :20-31
[9]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[10]   Nitric oxide - an endothelial cell survival factor [J].
Dimmeler, S ;
Zeiher, AM .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (10) :964-968